✦ LIBER ✦

Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy

✍ Scribed by Bajetta, Emilio; Zilembo, Nicoletta; Buzzoni, Roberto; Noberasco, Cristina; Celio, Luigi; Bichisao, Ettore

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4-Hydroxyandrostenedione (4-OHA) as firs

✍ Zilembo, N.; Bajetta, E.; Noberasco, C.; Buzzoni, R.; Martinetti, A.; Ferrari, L 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 164 KB

702 - 4-hydroxyandrostenedione (4-OHA) a

✍ C.S. Gennatas; J. Psychogios; C. Dardoufas; N. Tsavaris; S. Athanasiadis 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Phase II study of capecitabine and cispl

✍ Kang, H J; Chang, H M; Kim, T W; Ryu, M-H; Sohn, H J; Yook, J H; Oh, S T; Kim, B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Use of Capecitabine as First-Line Therap

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

A phase I/II study of 4′-O-tetrahydropyr

✍ Herbert Stöger, Thomas Bauernhofer, Marianne Schmid… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 474 KB

PCN92 COST-EFECTIVENESS ANALYSIS OF DOCE

✍ C Tenorio; J Vargas; J Martínez; Á Paladio 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB